Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

Efficacy and safety of upadacitinib in patients with active

Impact of Achieving Minimal Disease Activity on Patient-Reported

Disease Activity-Guided Stepwise Tapering but Not Discontinuation

Impact of Achieving ASDAS LDA on Disease Activity and Patient

PDF) Recommendations of the French Society for Rheumatology. TNFα

IJMS, Free Full-Text

PDF) AB0002 Sirt-1 Activity in PBMC from Patients with

PDF) Response to lower dose TNF inhibitors in axial

744, PDF, Rheumatoid Arthritis

Treating to Target(s) With Interleukin-17 Inhibitors - Charles W

Disease Control Data, Ankylosing Spondylitis

Treat-to-target in axial spondyloarthritis — what about physical